Haim Werner

12.4k total citations · 1 hit paper
195 papers, 9.7k citations indexed

About

Haim Werner is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, Haim Werner has authored 195 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Endocrinology, Diabetes and Metabolism, 120 papers in Molecular Biology and 49 papers in Cancer Research. Recurrent topics in Haim Werner's work include Growth Hormone and Insulin-like Growth Factors (135 papers), Metabolism, Diabetes, and Cancer (78 papers) and Cancer, Hypoxia, and Metabolism (44 papers). Haim Werner is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (135 papers), Metabolism, Diabetes, and Cancer (78 papers) and Cancer, Hypoxia, and Metabolism (44 papers). Haim Werner collaborates with scholars based in Israel, United States and Germany. Haim Werner's co-authors include Charles T. Roberts, Derek LeRoith, Dana Beitner‐Johnson, Rive Sarfstein, Ilan Bruchim, Derek LeRoith, Zvi Laron, Carolyn A. Bondy, Frank J. Rauscher and Martin L. Adamo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Haim Werner

192 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor

1995 1.2k citations Derek LeRoith, Haim Werner et al. Endocrine Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haim Werner Israel	52	5.4k	4.8k	2.0k	1.5k	1.5k	195	9.7k
Gunnar Norstedt Sweden	56	4.3k 0.8×	4.9k 1.0×	1.5k 0.7×	2.2k 1.4×	2.2k 1.5×	164	10.5k
Cheryl A. Conover United States	63	5.9k 1.1×	6.8k 1.4×	2.3k 1.1×	1.7k 1.1×	1.3k 0.9×	239	13.8k
Youngman Oh United States	46	3.9k 0.7×	4.7k 1.0×	1.7k 0.9×	1.1k 0.7×	722 0.5×	101	7.4k
Liam J. Murphy Canada	52	3.4k 0.6×	3.9k 0.8×	871 0.4×	1.8k 1.2×	873 0.6×	159	8.4k
Shoshana Yakar United States	61	6.8k 1.3×	6.9k 1.4×	2.1k 1.0×	2.1k 1.4×	2.0k 1.3×	172	13.7k
Peter Rotwein United States	60	8.0k 1.5×	7.2k 1.5×	1.7k 0.8×	3.2k 2.1×	1.3k 0.9×	196	13.5k
Michael J. Waters Australia	53	3.3k 0.6×	5.0k 1.0×	1.1k 0.5×	1.5k 1.0×	1.3k 0.9×	200	8.5k
Matthew M. Rechler United States	63	6.4k 1.2×	7.1k 1.5×	1.6k 0.8×	1.9k 1.3×	642 0.4×	163	11.2k
A. Joseph D’Ercole United States	57	5.2k 1.0×	6.7k 1.4×	1.0k 0.5×	2.7k 1.8×	562 0.4×	144	12.8k
J. Wesley Pike United States	61	4.4k 0.8×	1.7k 0.3×	572 0.3×	3.6k 2.4×	1.4k 0.9×	164	11.5k

Countries citing papers authored by Haim Werner

Since Specialization

Citations

This map shows the geographic impact of Haim Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haim Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haim Werner more than expected).

Fields of papers citing papers by Haim Werner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haim Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haim Werner. The network helps show where Haim Werner may publish in the future.

Co-authorship network of co-authors of Haim Werner

This figure shows the co-authorship network connecting the top 25 collaborators of Haim Werner. A scholar is included among the top collaborators of Haim Werner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haim Werner. Haim Werner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laron, Zvi & Haim Werner. (2025). Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications. Endocrine Reviews. 46(6). 877–890.

Hantisteanu, Shay, et al.. (2024). IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer. Frontiers in Oncology. 14. 1410447–1410447.

Werner, Haim. (2023). New Insights into the Role of the Insulin-Like Growth Factors in Breast Cancer. Medical Research Archives. 11(4). 1 indexed citations

Werner, Haim. (2023). The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities. International Journal of Molecular Sciences. 24(19). 14882–14882. 70 indexed citations

Laron, Zvi & Haim Werner. (2023). Administration of insulin like growth factor I (IGF I) lowers serum lipoprotein(a)-impact on atherosclerotic cardiovascular disease. Growth Hormone & IGF Research. 71. 101548–101548. 4 indexed citations

Werner, Haim & Derek LeRoith. (2022). Hallmarks of cancer: The insulin-like growth factors perspective. Frontiers in Oncology. 12. 1055589–1055589. 15 indexed citations

Werner, Haim, Rive Sarfstein, & Ilan Bruchim. (2019). Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy. Expert Opinion on Investigational Drugs. 28(12). 1101–1112. 48 indexed citations

Nagaraj, Karthik, Rive Sarfstein, David Gurwitz, et al.. (2018). Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action. Proceedings of the National Academy of Sciences. 115(5). 1045–1050. 49 indexed citations

Bruchim, Ilan, Rive Sarfstein, Ari Reiss, Eliezer Flescher, & Haim Werner. (2014). IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer. Cancer Letters. 352(2). 214–219. 5 indexed citations

10.

Bruchim, Ilan, Rive Sarfstein, & Haim Werner. (2014). The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches. Frontiers in Endocrinology. 5. 76–76. 68 indexed citations

11.

Bruchim, Ilan & Haim Werner. (2013). Targeting IGF-1 signaling pathways in gynecologic malignancies. Expert Opinion on Therapeutic Targets. 17(3). 307–320. 54 indexed citations

12.

Bentov, Itay, et al.. (2011). Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines. Gynecologic Oncology. 121(2). 383–389. 25 indexed citations

13.

Sarfstein, Rive, Metsada Pasmanik‐Chor, Adva Yeheskel, et al.. (2011). Insulin-like Growth Factor-I Receptor (IGF-IR) Translocates to Nucleus and Autoregulates IGF-IR Gene Expression in Breast Cancer Cells. Journal of Biological Chemistry. 287(4). 2766–2776. 76 indexed citations

14.

Aiello, Aurora, Giuseppe Pandini, Rive Sarfstein, et al.. (2010). HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene. European Journal of Cancer. 46(10). 1919–1926. 29 indexed citations

15.

Ravid, Dana, et al.. (2006). Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways. Experimental Cell Research. 312(19). 3899–3908. 26 indexed citations

16.

Idelman, Gila, Tova Glaser, Charles T. Roberts, & Haim Werner. (2003). WT1-p53 Interactions in Insulin-like Growth Factor-I Receptor Gene Regulation. Journal of Biological Chemistry. 278(5). 3474–3482. 61 indexed citations

17.

Werner, Haim, Zila Shen‐Orr, Frank J. Rauscher, et al.. (1995). Inhibition of Cellular Proliferation by the Wilms’ Tumor Suppressor WT1 Is Associated with Suppression of Insulin-Like Growth Factor I Receptor Gene Expression. Molecular and Cellular Biology. 15(7). 3516–3522. 92 indexed citations

18.

Eshet, R., Haim Werner, B. Klinger, et al.. (1993). Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. Journal of Molecular Endocrinology. 10(2). 115–120. 39 indexed citations

19.

Adamo, Martin L., F Lanau, Stefan Neuenschwander, et al.. (1993). Distinct promoters in the rat insulin-like growth factor-I (IGF-I) gene are active in CHO cells.. Endocrinology. 132(2). 935–937. 24 indexed citations

20.

Werner, Haim. (1992). Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Molecular Endocrinology. 6(10). 1545–1558. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact